Login / Signup

The rationale and development of a CyberKnife© registry for pediatric patients with CNS lesions.

Laura-Nanna LohkampArne GrünJulius DenglerPeter VajkoczyVolker BudachMarkus Kufeldnull null
Published in: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery (2020)
The CyberKnife© registry intends to generate scientific evidence for all treatment- and outcome-related aspects in pediatric patients with treated CNS lesions. The registry may define safety and efficacy of CKRS in children and serve as a basis for future clinical trials, inter-methodological comparisons and changes of treatment algorithms.
Keyphrases
  • clinical trial
  • machine learning
  • blood brain barrier
  • young adults
  • combination therapy
  • newly diagnosed
  • phase iii
  • childhood cancer